Factitious disorder mimicking addiction to levodopa in a patient with advanced Parkinson's disease.
نویسندگان
چکیده
We report a 43-year-old woman with early-onset Parkinson's disease in whom neurological control was impaired by psychiatric co-morbidity including major depression and panic disorder. The patient also met criteria for factitious disorder that mimicked dopamine dysregulation syndrome resulting in severe clinical and social disability.
منابع مشابه
Munchausen syndrome as scorpion biting:a misdiagnosis
Factitious disorder as Munchausen syndrome is a time and money consuming condition that is presented with different signs and symptoms. In emergent situations, it is not a differential diagnosis with high priority, but when it becomes recurrent with atypical symptoms, factitious disorder and malingering should be considered as well. In this survey, we report an odd and interesting presentation ...
متن کاملDopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Degeneration of the dopaminergic system in Parkinson's disease and longstanding exposure to dopaminergic drugs may cause reward system malfunction. This may manifest as addiction to l-dopa and behavioral disturbances associated with the impulse control system. These disturbances include: gambling, excessive spending (shopping), hypersexuality and binge eating. We included one such patient's per...
متن کاملگزارش 2مورد اختلال ساختگی با تظاهرات ریوی مشابه
INTRODUCING TWO CASES OF FACTITIOUS DISORDER WITH SAME PULMONARY PRESENTATION ABSTRACT Organic presentation is the main complain in psychiatric disorders which represent in different features, symptoms like shortness of breath and chronic cough are common when patient complication of pulmonary problems. One of the psychiatric disorder which presents with organic problems is factitious ...
متن کاملPatient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
The studies of duodenal infusion of a levodopa on small groups of parkinsonian patients have reported beneficial effects on motor complications. However, little is known about the patient profile and indications for duodenal levodopa infusion. The purpose of this study is to exhaustively investigate the clinical characteristics of the population and indication, efficacy and tolerability of duod...
متن کاملRopinirole therapy for Parkinson's disease.
Ropinirole (Requip, GlaxoSmithKline) is a novel nonergoline dopamine D2 agonist indicated for the treatment of early and advanced Parkinson's disease. It is mainly metabolized by the liver and its elimination half-life is approximately 5.8 h. When used as monotherapy in early Parkinson's disease, ropinirole improves signs and symptoms of the disorder. When used as an adjunct to levodopa in adva...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Arquivos de neuro-psiquiatria
دوره 63 2A شماره
صفحات -
تاریخ انتشار 2005